trimethyloxamine has been researched along with ST Elevated Myocardial Infarction in 7 studies
trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We enrolled 1004 patients with STEMI undergoing percutaneous coronary intervention (PCI)." | 1.91 | Prognostic value of gut microbiota-derived metabolites in patients with ST-segment elevation myocardial infarction. ( Cao, M; Fang, S; Han, T; Lin, K; Liu, X; Qin, Z; Tian, J; Tian, M; Tian, Y; Wang, S; Wang, Y; Wang, Z; Xu, J; Yang, F; Yin, H; Yu, B; Zhang, G; Zhang, Y; Zhao, P; Zhao, S, 2023) |
| "45." | 1.62 | Association of plasma trimethylamine N-Oxide level with healed culprit plaques examined by optical coherence tomography in patients with ST-Segment elevation myocardial infarction. ( Chen, R; Chen, Y; Li, J; Liu, C; Sheng, Z; Song, L; Tan, Y; Yan, H; Zhao, H; Zhou, J; Zhou, P, 2021) |
| "ACS and incident post-STEMI MACE may be associated with the gut bacteria choline metabolite TMAO." | 1.56 | Gut microbial taxa as potential predictive biomarkers for acute coronary syndrome and post-STEMI cardiovascular events. ( Dou, J; Gao, J; Liu, Y; Ma, J; Ren, M; Wang, J; Wang, JX; Yan, KT; Zhang, X, 2020) |
| "The median TMAO levels in patients with STEMI and healthy controls were 2." | 1.51 | Relation of Circulating Trimethylamine N-Oxide With Coronary Atherosclerotic Burden in Patients With ST-segment Elevation Myocardial Infarction. ( Chen, R; Chen, Y; Li, J; Liu, C; Sheng, Z; Song, L; Tan, Y; Yan, H; Zhao, H; Zhou, J; Zhou, P, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, S | 1 |
| Tian, Y | 1 |
| Wang, S | 1 |
| Yang, F | 1 |
| Xu, J | 1 |
| Qin, Z | 1 |
| Liu, X | 1 |
| Cao, M | 1 |
| Zhao, P | 1 |
| Zhang, G | 1 |
| Wang, Z | 2 |
| Zhang, Y | 1 |
| Wang, Y | 1 |
| Lin, K | 1 |
| Fang, S | 1 |
| Han, T | 1 |
| Tian, M | 1 |
| Yin, H | 1 |
| Tian, J | 1 |
| Yu, B | 1 |
| Matsuzawa, Y | 1 |
| Nakahashi, H | 1 |
| Konishi, M | 1 |
| Sato, R | 1 |
| Kawashima, C | 1 |
| Kikuchi, S | 1 |
| Akiyama, E | 1 |
| Iwahashi, N | 1 |
| Maejima, N | 1 |
| Okada, K | 1 |
| Ebina, T | 1 |
| Hibi, K | 1 |
| Kosuge, M | 1 |
| Ishigami, T | 1 |
| Tamura, K | 1 |
| Kimura, K | 1 |
| Gao, J | 1 |
| Yan, KT | 1 |
| Wang, JX | 1 |
| Dou, J | 1 |
| Wang, J | 1 |
| Ren, M | 1 |
| Ma, J | 1 |
| Zhang, X | 1 |
| Liu, Y | 1 |
| Tan, Y | 4 |
| Zhou, J | 4 |
| Liu, C | 4 |
| Zhou, P | 4 |
| Sheng, Z | 4 |
| Li, J | 4 |
| Chen, R | 3 |
| Song, L | 4 |
| Zhao, H | 4 |
| Xu, B | 2 |
| Gao, R | 2 |
| Yan, H | 4 |
| Chen, Y | 3 |
| Wang, L | 1 |
| Qian, H | 1 |
| Sun, Z | 1 |
| Qiao, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pre-intervention and Post-intervention Optical Coherence Tomography Examination for Culprit Lesion in Patients With ST-segment Elevation Myocardial Infarction[NCT03593928] | 400 participants (Anticipated) | Observational | 2017-03-29 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 other studies available for trimethyloxamine and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Prognostic value of gut microbiota-derived metabolites in patients with ST-segment elevation myocardial infarction.
Topics: Gastrointestinal Microbiome; Humans; Percutaneous Coronary Intervention; Prognosis; ST Elevation Myo | 2023 |
Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI.
Topics: Aged; Biomarkers; Coronary Angiography; Disease Progression; Female; Follow-Up Studies; Gastrointest | 2019 |
Gut microbial taxa as potential predictive biomarkers for acute coronary syndrome and post-STEMI cardiovascular events.
Topics: Acute Coronary Syndrome; Adult; Biomarkers; Female; Gastrointestinal Microbiome; Humans; Male; Methy | 2020 |
Association Between Plasma Trimethylamine N-oxide and Neoatherosclerosis in Patients With Very Late Stent Thrombosis.
Topics: Atherosclerosis; Biomarkers; Coronary Vessels; Disease Progression; Drug-Eluting Stents; Female; Fol | 2020 |
Association of plasma trimethylamine N-Oxide level with healed culprit plaques examined by optical coherence tomography in patients with ST-Segment elevation myocardial infarction.
Topics: Aged; Biomarkers; Chromatography, Liquid; Coronary Artery Disease; Coronary Vessels; Female; Humans; | 2021 |
Relation of Circulating Trimethylamine N-Oxide With Coronary Atherosclerotic Burden in Patients With ST-segment Elevation Myocardial Infarction.
Topics: Atherosclerosis; Biomarkers; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Female | 2019 |
Plasma Trimethylamine N-Oxide as a Novel Biomarker for Plaque Rupture in Patients With ST-Segment-Elevation Myocardial Infarction.
Topics: Aged; Biomarkers; Chromatography, High Pressure Liquid; Coronary Artery Disease; Cross-Sectional Stu | 2019 |